Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution
Abstract Purpose Medicines in special situations (MSS) refer to off‐label or to unlicensed drugs under investigation (compassionate use). Our objectives were to evaluate characteristics and to estimate overall survival (OS), event‐free survival (EFS), and the duration of treatment (DT) of MSS used f...
Main Authors: | Sandra Fontanals, Anna Esteve, Andrea González, Cristina Ibáñez, Javier Martínez, Ricard Mesía, Ana Clopés |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6360 |
Similar Items
-
Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience
by: Sandra Fontanals, et al.
Published: (2024-02-01) -
Off-label prescription of drugs at hospital
by: Vicente Arocas Casañ, et al.
Published: (2016-03-01) -
Off-label antineoplastic drugs. An effectiveness and safety study
by: Cristina Arroyo Álvarez, et al.
Published: (2017-05-01) -
Use of oral antineoplastic in special situations in a third level hospital: real life results
by: José Miguel Ferrari-Piquero, et al.
Published: (2018-01-01) -
Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)